Pudugrammam Krishna Iyer Vaidyanathan

Pudugrammam Krishna Iyer Vaidyanathan

Active Director Director DIN 00078261
DIN 00078261 First appointment Oct 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 2 historical roles
Total affiliations 9 Since Oct 2003
Shareholding value •••• Premium profile

About Pudugrammam Krishna Iyer Vaidyanathan

Data last updated:

Pudugrammam Krishna Iyer Vaidyanathan is a Director at Rhine Biogenics Private Limited (since 2003), Director at Rineus Health Care Company Private Limited (since 2013) and Director at Renolife Pharma (India) Private Limited (since 2010), and holds 4 more current directorships. The companies operate in Pharma, Healthcare and Chemicals. The 6 current companies with reported revenue have a combined latest revenue of ₹79.04 Cr; the largest is Rhine Biogenics Private Limited at ₹53.20 Cr (FY 2025). Earlier, Pudugrammam Krishna Iyer Vaidyanathan was a Director at Maya Biotech Private Limited (2016–2018) and Director at Rhine Formulations Private Limited (2015–2018).

DIN 00078261
Primary Designation Director
Industry Pharma
First Appointment 08 Oct 2003
Oldest Company Age 23 yrs
Largest company Rhine Biogenics Private Limited · ₹53.20 Cr (FY 2025)
Combined revenue ₹79.04 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhine Biogenics Private Limited U24232KL2003PTC016519
Director08 Oct 20032003₹53.20 Cr (FY 2025)Active
Director05 Mar 20132012₹8.76 Cr (FY 2025)Active
Director11 Jun 20102008₹7.51 Cr (FY 2024)Active
Rhine Life Sciences Private Limited U24232KL2006PTC019505
Director08 Jun 20062006₹5.14 Cr (FY 2025)Active
Director22 Feb 20192019₹4.42 Cr (FY 2025)Active
Moselle Drugs And Cosmetics Limited U24290HR2019PLC077772
Director10 Jan 20192019₹27,804 (FY 2024)Active
Partner10 Apr 20182017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maya Biotech Private Limited U55101CH1998PTC021391
Director09 Feb 20161998₹42.50 Cr (FY 2024)Active
Rhine Formulations Private Limited U15400CH2015PTC035487
Director15 Apr 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Pudugrammam Krishna Iyer Vaidyanathan

NameDINCompanyDesignation
Ajith Sukumaran Nair02461182Rhine Biogenics Private LimitedDirector
Ajitkumar Warrior00078332Rhine Biogenics Private Limited , Rineus Health Care Company Private Limited and 2 moreDirector
Jayakumar Narayanan Nair00078347Rhine Biogenics Private LimitedDirector
Kallungal Unni Jothish00362736Rhine Biogenics Private LimitedDirector
Madathiveetil Ramesh00362780Rhine Biogenics Private LimitedDirector
Peter Jose Ansal Parriathcherry02491672Rhine Biogenics Private Limited , Rhine Life Sciences Private Limited and 1 moreDirector
Reji Joy00132817Rhine Biogenics Private Limited , Rhine Life Sciences Private Limited and 1 moreDirector
Tirunilayi Krishnan Venugopal00078223Rhine Biogenics Private Limited , Rineus Health Care Company Private Limited and 3 moreManaging Director
Vinod Menon Kumar00362755Rhine Biogenics Private LimitedDirector
Anil Kumar Radhakrishnan05238878Rineus Health Care Company Private LimitedDirector
Kadalikattu Bijukumar Muraleedharan Pillai05324415Rineus Health Care Company Private LimitedDirector
Santhosh Velayudhan06556729Rineus Health Care Company Private LimitedDirector
Shinoj Prabhakaran06879584Rineus Health Care Company Private LimitedDirector
Subhash Parameswaran05238884Rineus Health Care Company Private LimitedManaging Director
Kandamkulathy Lazar Lazar02294271Renolife Pharma (India) Private LimitedManaging Director
Mullothu Gopalakrishnan Krishnakumar02694179Renolife Pharma (India) Private LimitedDirector
Pariyarath Nandakumar02693441Renolife Pharma (India) Private LimitedDirector
Shaji Thuvakkunnon02693416Renolife Pharma (India) Private LimitedDirector
Manoj Mathew02825008Rhine Life Sciences Private LimitedDirector
Porai Chacko Raphael00132833Rhine Life Sciences Private LimitedDirector
Rajimon Kolakkal00132838Rhine Life Sciences Private Limited , R-Vision Eye Hospital Private LimitedDirector
Santhosh Bhaskaran07105715Rhine Life Sciences Private LimitedDirector
Ramesh Hariharan08371924R-Vision Eye Hospital Private LimitedManaging Director
Varsha Vaidyanath09201607R-Vision Eye Hospital Private LimitedDirector
Ganapathy Venkatachalam Iyer08327931Moselle Drugs And Cosmetics LimitedDirector

Directorship timeline

Open interactive timeline →
Leo Clinical Diagnostic Centre Llp
Rineus Health Care Company Private Limited
Rhine Biogenics Private Limited
Rhine Life Sciences Private Limited
Premium access

Shareholding and investment profile for Pudugrammam Krishna Iyer Vaidyanathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pudugrammam Krishna Iyer Vaidyanathan

Pudugrammam Krishna Iyer Vaidyanathan currently holds 7 directorships: Rhine Biogenics Private Limited (Director, since 08 Oct 2003, revenue ₹53.20 Cr (FY 2025)); Rineus Health Care Company Private Limited (Director, since 05 Mar 2013, revenue ₹8.76 Cr (FY 2025)); Renolife Pharma (India) Private Limited (Director, since 11 Jun 2010, revenue ₹7.51 Cr (FY 2024)); Rhine Life Sciences Private Limited (Director, since 08 Jun 2006, revenue ₹5.14 Cr (FY 2025)); R-Vision Eye Hospital Private Limited (Director, since 22 Feb 2019, revenue ₹4.42 Cr (FY 2025)); and 2 more.

Pudugrammam Krishna Iyer Vaidyanathan was first appointed on 08 Oct 2003 as Director at Rhine Biogenics Private Limited. The most recent appointment on record is 22 Feb 2019 at R-Vision Eye Hospital Private Limited.

The 6 current companies of Pudugrammam Krishna Iyer Vaidyanathan that report revenue have a combined latest revenue of ₹79.04 Cr: Rhine Biogenics Private Limited ₹53.20 Cr (FY 2025); Rineus Health Care Company Private Limited ₹8.76 Cr (FY 2025); Renolife Pharma (India) Private Limited ₹7.51 Cr (FY 2024); Rhine Life Sciences Private Limited ₹5.14 Cr (FY 2025); R-Vision Eye Hospital Private Limited ₹4.42 Cr (FY 2025); and 1 more.

Pudugrammam Krishna Iyer Vaidyanathan held 2 earlier board appointments: Maya Biotech Private Limited (Director, 09 Feb 2016 to 01 Nov 2018); Rhine Formulations Private Limited (Director, 15 Apr 2015 to 31 Jan 2018).

The current boards of Pudugrammam Krishna Iyer Vaidyanathan's companies include Ajith Sukumaran Nair (Rhine Biogenics Private Limited), Ajitkumar Warrior (Rhine Biogenics Private Limited), Jayakumar Narayanan Nair (Rhine Biogenics Private Limited), Kallungal Unni Jothish (Rhine Biogenics Private Limited), Madathiveetil Ramesh (Rhine Biogenics Private Limited), Peter Jose Ansal Parriathcherry (Rhine Biogenics Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available